Equities researchers at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report issued on Saturday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens raised their price objective on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.
View Our Latest Report on MDRX
Veradigm Stock Performance
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- Growth Stocks: What They Are, What They Are Not
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What Are Some of the Best Large-Cap Stocks to Buy?
- 5 Best Gold ETFs for March to Curb Recession Fears
- What is the FTSE 100 index?
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
